Crypto Industry Faces Uncertainty as Influential Executives Face Legal Troubles

  • 📰 smh
  • ⏱ Reading Time:
  • 27 sec. here
  • 12 min. at publisher
  • 📊 Quality Score:
  • News: 49%
  • Publisher: 80%

Finance Nyheter

Bitcoin,Crypto,Digital Currencies

Major financial firms are showing renewed interest in digital currencies as the price of bitcoin surges. However, the industry's most influential executives, Sam Bankman-Fried and Changpeng Zhao, are facing prison time. This has led to a scramble for influence among crypto entrepreneurs, Wall Street executives, and government regulators, which could determine the future of crypto in the United States.

The price of bitcoin is surging again. Major financial firms are showing renewed interest in digital currencies. And crypto fanatics are celebrating the end of a long period of depressed prices and business collapses. The last time crypto prices were skyrocketing, the industry’s most influential executives were Sam Bankman-Fried and Changpeng Zhao, rival billionaires whose online sparring could move markets.

Now Bankman-Fried, founder of the FTX crypto exchange, and Zhao, who ran the world’s largest crypto firm, Binance, both face prison time after parallel falls from power. With the two men out of the picture, a crowded field of crypto entrepreneurs, Wall Street executives and government regulators are vying to control the industry’s next chapter. Their scramble for influence could determine whether crypto survives in the United States, where a regulatory crackdown has made it increasingly difficult for the industry to operate

 

Tack för din kommentar. Din kommentar kommer att publiceras efter att ha granskats.
Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

 /  🏆 6. in SE

Sverige Senaste nytt, Sverige Rubriker

Similar News:Du kan också läsa nyheter som liknar den här som vi har samlat in från andra nyhetskällor.

Pathology Company Healius Faces Financial StrugglesHealius, a pathology company in Australia, is experiencing a decline in its sharemarket capitalisation and had to undergo an emergency capital raising. The chairwoman resigned before facing a potential vote for re-election.
Källa: FinancialReview - 🏆 2. / 90 Läs mer »